0001493152-21-023406.txt : 20210922
0001493152-21-023406.hdr.sgml : 20210922
20210922173459
ACCESSION NUMBER: 0001493152-21-023406
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210920
FILED AS OF DATE: 20210922
DATE AS OF CHANGE: 20210922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Malley Brendan M.
CENTRAL INDEX KEY: 0001884342
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 211270391
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
3
1
ownership.xml
X0206
3
2021-09-20
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001884342
O'Malley Brendan M.
1330 AVENUE OF THE AMERICAS,
33RD FLOOR
NEW YORK
NY
10019
0
1
0
0
SVP, General Counsel
Common stock
137454
D
Stock Option (right to buy)
1.15
2029-05-31
Common stock
55000
D
Stock Option (right to buy)
1.15
2030-03-16
Common stock
50000
D
Stock Option (right to buy)
2.34
2031-03-01
Common stock
100000
D
Includes 130,113 shares of unvested restricted stock, which will vest on various dates between September 30, 2021 and March 1, 2025.
The options vest 25% on May 31, 2020, and in 36 equal monthly installments thereafter.
The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter.
The options vest 25% on March 1, 2022, and in 36 equal monthly installments thereafter.
/s/ Brendan O'Malley
2021-09-22